Skip to main content

Advertisement

Log in

Lung Cancer OncoGuia

  • Special Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Manchon P, Borràs JM (2009) Clinical practice guidelines for cancer care: what are they for? Clin Trans Oncol 11:775–776

    Article  Google Scholar 

  2. Borràs JM, Piñol JL, Izquierdo A, Borràs J (2008) Análisis de la incidencia, la supervivencia y la mortalidad según las principales localizaciones tumorales 1985–2019: Cáncer de pulmón. Med Clin (BCN) 131[Suppl 1]:53–57

    Article  Google Scholar 

  3. Detterbeck FC, Jones DR, Parker LA Jr (2001) Diagnosis and treatment of lung cancer: an evidence based guide for the practicing clinician. WB Saunders Co, Philadelphia, PA, pp 73–93

    Google Scholar 

  4. López-Encuentra A, Villena V, Galán A, Nieto A (1998) Diágnostico y estadificación del cáncer de pulmón. In: Caminero JA, Fernández L (eds) Manual de Neumología y Cirugía Torácica, Vol. II. Editores Médicos S.A., Madrid, pp 1497–1510

    Google Scholar 

  5. European Society for Medical Oncology (ESMO) (2001) ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer. ESMO, Viganello-Lugano, Switzerland. http://www.esmoorg/reference/referenceGuidelines/pdf/ESMO_03_non_small_cell_lung_cancer.pdf. Accessed 12 December 2002

  6. Rivera MP, Mehta AC (2007) Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132[3 Suppl]:131S–148S

    Article  PubMed  Google Scholar 

  7. Grupo Cooperativo de Carcinoma Broncogénico de la Sda. Española de Neumología i C. Torácica (GCCB-S) (2001) Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol 2001;37(11):495–503

    Google Scholar 

  8. Burnett RA, Swanson BJ, Howatson SR et al (1994) Observer variability in histopathological reporting of malignant bronchial biopsy specimens. J Clin Pathol 47:711–713

    Article  CAS  PubMed  Google Scholar 

  9. Kern WH (1988) The diagnostic accuracy of sputum and urine cytology. Acta Cytol 32:651–654

    CAS  PubMed  Google Scholar 

  10. Ng AB, Horak GC (1983) Factors significant in the diagnostic accuracy of lung cytology in bronchial washing and sputum samples. II. Sputum samples. Acta Cytol 27:397–402

    CAS  PubMed  Google Scholar 

  11. NICE (2005) The diagnosis and treatment of lung cancer. National Institute for Clinical Excellence, London

    Google Scholar 

  12. Rintoul RC, Skwarski KM, Murchison JT et al (2005) Endobronchial and endoscopic ultrasoundguided real-time fine-needle aspiration for mediastinal staging. Eur Respir J 25:416–421

    Article  CAS  PubMed  Google Scholar 

  13. Yasufuku K, Chiyo M, Koh E et al (2005) Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 50:347–354

    Article  PubMed  Google Scholar 

  14. Klein JS, Zarka MA (1997) Transthoracic needle biopsy: an overview. J Thorac Imaging 12:232–249

    Article  CAS  PubMed  Google Scholar 

  15. Moore EH (1997) Needle-aspiration lung biopsy: a comprehensive approach to complication reduction. J Thorac Imaging 12:259–271

    Article  CAS  PubMed  Google Scholar 

  16. (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 99–103

  17. Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714

    Article  PubMed  Google Scholar 

  18. Glazer GM, Gross BH, Quint LE et al (1985) Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144:261–265

    CAS  PubMed  Google Scholar 

  19. Goldstraw P, Rocmans P, Ball D et al (1994) Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report. Lung Cancer 11[Suppl 3]:S1–S4

    Article  PubMed  Google Scholar 

  20. Goldstraw P (1997) Report on the international workshop on intrathoracic staging. London, October 1996. Lung Cancer 18:107–111

    Article  Google Scholar 

  21. Gdeedo A, Van Schil P, Corthouts B et al (1997) Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 12: 224–227

    Article  CAS  PubMed  Google Scholar 

  22. Glazer HS, Kaiser LR, Anderson DJ et al (1989) Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 173: 37–42

    CAS  PubMed  Google Scholar 

  23. Heelan RT, Demas BE, Caravelli JF et al (1989) Superior sulcus tumors: CT and MR imaging. Radiology 170:637–641

    CAS  PubMed  Google Scholar 

  24. Beale R, Slater R, Hennington M, Keagy B (1992) Pancoast tumor: use of MRI for tumor staging. South Med J 85:1260–1263

    Article  CAS  PubMed  Google Scholar 

  25. Quint LE, Glazer GM, Orringer MB (1987) Central lung masses: prediction with CT of need for pneumonectomy versus lobectomy. Radiology 165:735–738

    CAS  PubMed  Google Scholar 

  26. Micames CG, McCrory DC, Pavey DA et al (2007) Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest 131:539–548

    Article  PubMed  Google Scholar 

  27. Annema JT, Versteegh MI, Veselic M et al (2005) Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol 23:8357–8361

    Article  PubMed  Google Scholar 

  28. Annema JT, Versteegh MI, Veselic M et al (2005) Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA 294:931–936

    Article  CAS  PubMed  Google Scholar 

  29. Wiersema MJ, Vazquez-Sequeiros E, Wiersema LM (2001) Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy. Radiology 219:252–257

    CAS  PubMed  Google Scholar 

  30. Alongi F, Ragusa P, Montemaggi P, Bona CM (2006) Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer. Tumori 92:327–333

    PubMed  Google Scholar 

  31. Gould MK, Kuschner WG, Rydzak CE et al (2003) Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 139:879–892

    PubMed  Google Scholar 

  32. Yi CA, Lee KS, Kim BT et al (2007) Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR Am J Roentgenol 188:318–325

    Article  PubMed  Google Scholar 

  33. Kim BT, Lee KS, Shim SS et al (2006) Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT: a prospective study. Radiology 241:501–509

    Article  PubMed  Google Scholar 

  34. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA et al (2005) Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol 23:8348–8356

    Article  PubMed  Google Scholar 

  35. Shim SS, Lee KS, Kim BT et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236:1011–1019

    Article  PubMed  Google Scholar 

  36. Silvestri GA, Littenberg B, Colice GL (1995) The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med 152:225–230

    CAS  PubMed  Google Scholar 

  37. Marquez Perez FL, Blasco FR, Callol SL et al (1998) Valor de los datos clínicos en la predicción de metástasis óseas estudiadas por rastreo isotópico en el carcinoma broncogénico. Arch Bronconeumol 34:484–488

    CAS  PubMed  Google Scholar 

  38. Lardinois D, Weder W, Roudas M et al (2005) Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 23:6846–6853

    Article  PubMed  Google Scholar 

  39. Colice GL, Shafazand S, Griffin JP et al (2007) Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132[3 Suppl]:161S–177S

    Article  PubMed  Google Scholar 

  40. Varela-Simo G, Barbera-Mir JA, Cordovilla-Perez R et al (2005) [Guidelines for the evaluation of surgical risk in bronchogenic carcinoma]. Arch Bronconeumol 41:686–697

    CAS  PubMed  Google Scholar 

  41. Carrillo F, Cueto A, Díaz JP et al (2005) Normativa Terapéutica del carcinoma broncogénico. Recomendaciones SEPAR. 38. Available at: http://www.separ.es/publicaciones/normativas_y_procedimientos.html

  42. Nesbitt JC, Putnam JB Jr, Walsh GL et al (1995) Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60:466–472

    Article  CAS  PubMed  Google Scholar 

  43. Ettinger DS, Akerley W, Bepler G et al; National Comprehensive Cancer Network (NCCN) (2008) Non-small cell lung cancer clinical practice guidelines in oncology. Available at: www.nccn.org

  44. Arriagada R, Bergman B, Dunant A et al (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351–360

    Article  PubMed  Google Scholar 

  45. Pignon JP, Tribodet H, Scagliotti GV et al (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552–3559

    Article  PubMed  Google Scholar 

  46. American Society of Clinical Oncology (ASCO) (1997) Clinical practice guidelines for the treatment of unresectable non-small-cell. ASCO, Alexandria, VA. Available at: http://www.asco.org/asco/downloads/Unresectable_NonSmall_Cell_Lung_Cancer_Guideline.pdf. Accessed 19 November 2002

    Google Scholar 

  47. Rosell R, Gomez-Codina J, Camps C et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153–158

    Article  CAS  PubMed  Google Scholar 

  48. Roth JA, Fossella F, Komaki R et al (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86:673–680

    Article  CAS  PubMed  Google Scholar 

  49. Taylor NA, Liao ZX, Cox JD et al (2004) Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys 58:204–212

    Article  PubMed  Google Scholar 

  50. Albain KS, Swann RS, Rusch VR et al (2005) Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcome update of the North American Intergroup 0139 (RTOG 9309). J Clin Oncol 23:abstract 7014

    Google Scholar 

  51. Van Meerbeeck JP, Kramer G, Van Scil PE et al (2005) A randomised trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients with stage IIIA-N2 non small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941). J Clin Oncol 23:abstract 7015

    Google Scholar 

  52. Dillman RO, Herndon J, Seagren SL et al (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1215

    Article  CAS  PubMed  Google Scholar 

  53. Elias D, Lobillo J, Kumar P et al (1997) A phase III comparison of “best local-regional therapy” with or without chemotherapy (CT) for stage IIIA T1-3N2 non-small cell lung cancer (NSCLC): preliminary results. Proc Natl Acad Sci 16:A1611

    Google Scholar 

  54. Furuse K, Fukuoka M, Kawahara M et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692–2699

    CAS  PubMed  Google Scholar 

  55. Curran WJ Jr, Scott C, Langer C et al (2000) Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): Initial report of radiation therapy oncology group (RTOG) 9410. Proc Am Soc Clin Oncol 19:484

    Google Scholar 

  56. Hanna NH, Neubauer M, Ansari R et al (2008) Phase III trial of cisplatin plus etoposide plus concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small cell lung cancer: HOG LUN 01-24/USO-023. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I 25[18 Suppl]:7512

    Google Scholar 

  57. Schaake-Koning C, van den BW, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524–530

    CAS  PubMed  Google Scholar 

  58. Jett JR, Schild SE, Keith RL, Kesler KA (2007) Treatment of non-small cell lung cancer-stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:266–276

    Article  Google Scholar 

  59. Robinson LA, Ruckdeschel JC, Wagner H et al (2007) Treatment of non-small cell lung cancer stage IIIA. ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132:243S–265S

    Article  PubMed  Google Scholar 

  60. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909

    Google Scholar 

  61. NSCLC Meta-Analyses Collaborative Group (2008) Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26:4617–4625

    Article  Google Scholar 

  62. Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92–98

    Article  CAS  PubMed  Google Scholar 

  63. Ardizzoni A, Boni L, Tiseo M et al (2007) Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99:847–857

    Article  CAS  PubMed  Google Scholar 

  64. Grilli R, Oxman AD, Julian JA (1993) Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J Clin Oncol 11:1866–1872

    CAS  PubMed  Google Scholar 

  65. Smith IE, O’Brien ME, Talbot DC et al (2001) Duration of chemotherapy in advanced non-smallcell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol 19:1336–1343

    CAS  PubMed  Google Scholar 

  66. Park JO, Kim SW, Ahn JS et al (2007) Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. J Clin Oncol 25:5233–5239

    Article  CAS  PubMed  Google Scholar 

  67. Hanna N, Shepherd FA, Fossella FV et al (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589–1597

    Article  CAS  PubMed  Google Scholar 

  68. Shepherd FA, Rodrigues PJ, Ciuleanu T et al (2005) Erlotinib in previously treated non-smallcell lung cancer. N Engl J Med 353:123–132

    Article  CAS  PubMed  Google Scholar 

  69. Takada M, Fukuoka M, Kawahara M et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060

    Article  CAS  PubMed  Google Scholar 

  70. Turrisi AT III, Kim K, Blum R et al (1999) Twicedaily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271

    Article  CAS  PubMed  Google Scholar 

  71. Sundstrom S, Bremnes RM, Kaasa S et al (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672

    Article  CAS  PubMed  Google Scholar 

  72. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484

    CAS  Google Scholar 

  73. Bolliger CT, Heitz M, Hauser R et al (1996) An airway wallstent for the treatment of tracheobronchial malignancies. Thorax 51:1127–1129

    Article  CAS  PubMed  Google Scholar 

  74. Bolliger CT, Mathur PN, Beamis JF et al (2002) ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 19:356–373

    CAS  Google Scholar 

  75. Freitag L, Macha HN, Loddenkemper RA (2007) Interventional bronchoscopic procedures. In: Spiro SG (ed.) Lung cancer. Monograph 17. European Respiratory Society, Lausanne, Switzerland, pp 272–304

    Google Scholar 

  76. Mehta M, Shahabi S, Jarjour N et al (1990) Effect of endobronchial radiation therapy on malignant bronchial obstruction. Chest 97:662–665

    Article  CAS  PubMed  Google Scholar 

  77. Valipour A, Kreuzer A, Koller H et al (2005) Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 127:2113–2118

    Article  PubMed  Google Scholar 

  78. Morice RC, Ece T, Ece F et al (2008) Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest 118:516–521

    Google Scholar 

  79. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 15:893–900

    CAS  PubMed  Google Scholar 

  80. Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for smallcell lung cancer. N Engl J Med 327:1618–1624

    CAS  PubMed  Google Scholar 

  81. Arriagada R, Le Chevalier T, Riviere A et al (2002) Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 13:748–754

    Article  CAS  PubMed  Google Scholar 

  82. Slotman B, Faivre-Finn C, Kramer G et al (2007) Prophylactic cranial irradiation in extensive smallcell lung cancer. N Engl J Med 357:664–672

    Article  CAS  PubMed  Google Scholar 

  83. Langendijk JA, Aaronson NK, de Jong JM et al (2001) Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol 19:2123–2133

    CAS  PubMed  Google Scholar 

  84. Hayakawa K, Mitsuhashi N, Katano S et al (2001) High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32:81–88

    Article  CAS  PubMed  Google Scholar 

  85. Rowell NP, Williams CJ (2001) Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 56:628–638

    Article  CAS  PubMed  Google Scholar 

  86. Scott WJ, Howington J, Feigenberg S et al (2007) Treatment of non-small cell lung cancer stage I and stage II. ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132:234S–242S

    Article  PubMed  Google Scholar 

  87. Burdett S, Stewart L (2005) Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 47:81–83

    Article  PubMed  Google Scholar 

  88. Senan S, Burgers S, Samson MJ et al (2002) Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54:999–1006

    Article  PubMed  Google Scholar 

  89. Yuan S, Sun X, Li M et al (2007) A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30:239–244

    Article  CAS  PubMed  Google Scholar 

  90. Engenhart R, Kimmig BN, Hover KH et al (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361

    Article  CAS  PubMed  Google Scholar 

  91. Flickinger JC, Kondziolka D, Lunsford LD et al (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802

    CAS  PubMed  Google Scholar 

  92. Laing RW, Warrington AP, Hines F et al (1993) Fractionated stereotactic external beam radiotherapy in the management of brain metastases. Eur J Cancer 29A:1387–1391

    Article  CAS  PubMed  Google Scholar 

  93. Nag S, Abitbol AA, Anderson LL et al (1993) Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society. Int J Radiat Oncol Biol Phys 27:1241–1244

    CAS  PubMed  Google Scholar 

  94. Marsiglia H, Baldeyrou P, Lartigau E et al (2000) High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 47:665–672

    Article  CAS  PubMed  Google Scholar 

  95. Ramírez J, Montero A, Alejo M, Lloreta J on behalf of the Lung Cancer OncoGuia Group (2009) Lung Cancer OncoGuia: surgical pathology report guidelines. Clin Trans Oncol 11:825–827

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to P. Manchon Walsh.

Additional information

Lung cancer experts are listed at the end of the article

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manchon Walsh, P., Aguiló, R., Alejo, M. et al. Lung Cancer OncoGuia. Clin Transl Oncol 11, 805–824 (2009). https://doi.org/10.1007/s12094-009-0449-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-009-0449-0

Keywords

Navigation